2,154
Views
0
CrossRef citations to date
0
Altmetric
Immunotherapy - Cancer

Vaccines targeting ESR1 activating mutations elicit anti-tumor immune responses and suppress estrogen signaling in therapy resistant ER+ breast cancer

, , , , , , , , , , , , , & ORCID Icon show all
Article: 2309693 | Received 13 Sep 2023, Accepted 19 Jan 2024, Published online: 08 Feb 2024